Insider trade

CEO exercised or converted 17K TMO derivative securities

Traded Oct 24, 2025 · Filed Oct 28, 2025

Thermo Fisher ScientificTMO

17K
Shares · @ $253.99

Why it stands out

Derivative exercise or conversion — not an open-market buy.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Oct 24, 2025
Reporting period: Not applicable
Filed with the SEC: Oct 28, 2025

CEOOption exercise

Context

Classification

option exercise

Code M — exercise or conversion of a derivative security

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0000097745-25-000152

Filed / recorded

Oct 28, 2025, 8:27 PM UTC

Added to OQRO

Oct 2, 2026, 12:28 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

THERMO FISHER SCIENTIFIC INC.

Issuer CIK

97745

Ticker

TMO

Reporting person

Marc N Casper

Relationship

Director, Officer

Officer title

Chairman & CEO

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

Oct 24, 2025

Transaction code

M

Shares / units

17,104

Price per share

$253.99

Acquired / disposed

Acquired (A)

Shares owned after

130,866.285

Ownership form

Direct

Amendment

No

Around the same time

11mo ago

8,475Shares · @ $253.99

Derivative exercise or conversion — not an open-market buy.

Why it stands out Official record

Officer sold ~$5.08M of Thermo Fisher Scientific

Scheduled in advance11mo ago

11mo ago

2,250Shares · @ $294.02

Derivative exercise or conversion — not an open-market buy.

Why it stands out Official record